e-learning
resources
Stockholm 2002
Sunday 15.09.2002
Prevalence and costs of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chronic obstructive pulmonary disease (COPD) and medicine comsumption in Italian general population samples
M. Simoni, G. Matteelli, A. Angino, F. Pistelli, S. Baldacci, E. Polverino, L. Carrozzi, G. Viegi (Pisa, Italy)
Source:
Annual Congress 2002 - Prevalence and costs of COPD
Session:
Prevalence and costs of COPD
Session type:
Thematic Poster Session
Number:
831
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Simoni, G. Matteelli, A. Angino, F. Pistelli, S. Baldacci, E. Polverino, L. Carrozzi, G. Viegi (Pisa, Italy). Chronic obstructive pulmonary disease (COPD) and medicine comsumption in Italian general population samples. Eur Respir J 2002; 20: Suppl. 38, 831
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
A 12-year-old male child with fever, productive cough and sudden onset paralysis
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Prevalence of chronic obstructive pulmonary disease (COPD) in a general population in Norway
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012
Awareness of chronic obstructive pulmonary disease (COPD) in Portugal general practicioners
Source: Eur Respir J 2007; 30: Suppl. 51, 129s
Year: 2007
Chronic obstructive pulmonary disease (COPD) – patient‘s perspective
Source: Eur Respir J 2007; 30: Suppl. 51, 168s
Year: 2007
Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Awareness of chronic obstructive pulmonary disease (COPD) in Portugal
Source: Eur Respir J 2007; 30: Suppl. 51, 126s
Year: 2007
Prevalence of chronic obstructive pulmonary disease (COPD) in Greece
Source: Eur Respir J 2002; 20: Suppl. 38, 122s
Year: 2002
COPD exacerbations in patients with chronic obstructive pulmonary disease in general practice in Ireland
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004
Drug prescribing and burden of asthma and chronic obstructive pulmonary disease (COPD): a study from Italian general practitioners
Source: Eur Respir J 2005; 26: Suppl. 49, 672s
Year: 2005
Dietary habits in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013
Prevalence of chronic obstructive pulmonary disease (COPD) in primary care
Source: Annual Congress 2008 - Issues in the management of COPD in the community
Year: 2008
Prescription of opioids for breathlessness in end-stage chronic obstructive pulmonary disease: A national population based study
Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Year: 2016
Chronic obstructive pulmonary disease (COPD) in children: is it possible?
Source: Eur Respir J 2005; 26: Suppl. 49, 63s
Year: 2005
Adherence to national (UK) respiratory guidelines in general practice
Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Year: 2007
Delivery of asthma and chronic obstructive pulmonary disease (COPD) services in UK primary care: nurses‘ roles and responsibilities
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007
Hypertension in chronic obstructive pulmonary disease (COPD): A review of current practice
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020
Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
Nomogram for patients with exacerbation in the general practitioners based Swiss chronic obstructive pulmonary disease cohort
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021
How to screen chronic obstructive pulmonary disease in general practice?
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015
Evaluation of the prevalence and of the charge of chronic obstructive pulmonary disease in Moroccan general practicians
Source: Eur Respir J 2004; 24: Suppl. 48, 494s
Year: 2004
Quality of life and disease burden of chronic obstructive pulmonary disease (COPD) patients in Northern Greece – The INCARE* study
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept